Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Clinical trial NCT00559975 · COMPLETED

Trial details

NCT number: NCT00559975
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Infection

Start date: 2007-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.